Lipocine signs supply and distribution agreement with Pharmalink for Tlando
Lipocine announced an exclusive supply and distribution agreement with Pharmalink to commercialize Tlando, its oral testosterone replacement therapy, in the Gulf Cooperation Council countries consisting of Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. Under the terms of the agreement, Lipocine received an upfront payment from Pharmalink and, upon Marketing Authorizations in individual GCC countries, Lipocine will provide Tlando drug product to Pharmalink at an agreed transfer price. Pharmalink will have the exclusive rights to Tlando throughout the GCC region and will be responsible for promotion, distribution and sale of the product in the territory.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LPCN:
Originally published by finance.yahoo.com. Syndicated material does not necessarily reflect the views of Grazia British.
More Culture
Don’t Pull Out of Germany
Merz’s stupidity is no excuse for a stupid response. Source link
Step inside the gorgeous, futuristic offices of Vast, the startup designing the next-gen space station
A tall baobab tree greets people inside the Long Beach, California, headquarters of Vast, an aerospace company that is building the space station of the future. It’s planted beneath a…
5 ways high-performing teams stay calm when everything’s on fire
When markets swing, plans break, inboxes explode, and everyone starts saying the situation is “unprecedented” again, most teams do what humans have always done under pressure: they grip…
Confused Trump Openly Admits Plot to Rig Midterms as Polls Turn Brutal
Last week, the Supreme Court gutted protections against racial gerrymandering, and Donald Trump is already urging Republicans to seize on it. Trump unleashed a Truth Social rant on Monday…